[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"motility-disorder\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:motility-disorder":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":31,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100631904","prospective-registry-of-esophageal-motility-100631904",false,"NCT07506746","PRospective Registry of Esophageal Motility","PREM","Inclusion Criteria:\n\n1. Participant is willing and able to give informed consent for participation in the study.\n2. The procedures are the standard of care for the patient or the participant is taking the medicinal product according to clinical practice\n3. Aged \\> 18 years.\n4. Any typical (heartburn or regurgitation) or atypical reflux symptom (Laryngeal Cough, laryngitis, sub-glottic stenosis, globus, laryngeal cancer, vocal cord granuloma, vocal cord irritation, vocal cord polyps and post-nasal drip; Oropharyngeal: Dental erosion, pharyngitis, sore or burning throat, gingivitis and halitosis; Ears and sinuses: Earaches, otitis media and sinusitis; Pulmonary: Chronic bronchitis, pneumonia, aspiration, bronchiectasis, asthma and idiopathic pulmonary fibrosis; Cardiac: Arrhythmia, angina and myocardial infarction; Sleep: Sleep apnoea, sleep deprivation, insomnia, snoring, nightmare and sleep disturbance), but also any obstructive esophageal symptom potentially reflecting a primary or secondary motility disorder (oropharyngeal or esophageal dysphagia, chest pain, bolus impaction). Every patient with a diagnosis of esophageal inflammatory disorder (including EoE and others) or systemic rheumatological condition (scleroderma, systemic sclerosis, lichen planus and others), every patient previously undergone to any anti-reflux surgery, bariatric surgery, endoscopic or surgical esophageal or gastric myotomy (also for gastroparesis) may be included.\n5. Patients must be referred to the Digestive Physiopathology Unit of IRCCS San Raffaele Hospital for motility tests\n\nExclusion Criteria:\n\n1. Age \\\u003C 18 years\n2. Not willing to provide informed consent to the inclusion in the registry",true,"ALL","18 Years",{"count":20,"type":21},10000,"ESTIMATED","10 Years","OBSERVATIONAL","Digestive physiopathology is a branch of gastroenterology aiming to study patients with upper GI symptoms, mainly gastro-esophageal, potentially indicating the presence of Gastroesophageal Reflux Disease (GERD)\u002FBarrett Esophagus (BE) or obstructive esophageal motility disorders (achalasia being the most relevant), but including also other primary motility disorders such as Esophgago-Gastric Junction Outflow Obstruction (EGJOO), Hypercontractile Esophagus (HE), Distal Esophageal Spasm (DES) and other minor disorders. Physiopathological testing encompasses High-Resolution Manometry (HRM), 24-H esophageal pH-impedance testing, Functional Lumen Imaging Probe (FLIP) assessment. All these tests are designed to provide a clear phenotyping of esophago-gastric disorders related to reflux or obstructive esophageal symptoms, either in naïve patients, as well as after foregut surgery (particularly anti-reflux surgery, achalasia\u002Fprimary motility disorders treatment).",[26,27,28,29,30],"Esophageal Diseases","Achalasia","Eosinophilic Esophagitis","Motility Disorder","GERD",[32],"Esophageal disease; manometry; FLIP, pH-impedance","RECRUITING","2026-03-28",{"date":36,"type":37},"2026-04-02","ACTUAL",{"date":39,"type":37},"2026-03-09",{"date":41,"type":21},"2041-03",{"name":43,"class":44},"IRCCS San Raffaele","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":55,"phases":56,"briefSummary":58,"conditions":59,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":45},"100428191","investigating-the-effects-of-wearable-robotic-exoskeleton-for-improving-mobility-and-cognition-in-persons-with-ms-100428191","NCT04855825","Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS","Inclusion Criteria:\n\n* Be diagnosed with multiple sclerosis.\n* Be determined by the study staff to have moderate to severe difficulty walking but still be able to walk while using the robotic exoskeleton.\n* Have some difficulty thinking and problem solving as determined by my performance on a special test that I will take during the screening visit.\n* Be between the ages of 18 and 75.\n* Be free from flair ups of my MS Symptoms for at least one month prior to testing.\n* Discuss with study staff how to maintain a constant level of my spasticity medication (for example baclofen) throughout the study.\n* Be able to walk (with the use of one or more assistive device if needed).\n* Have English as my primary language.\n* Be able to physically fit into the exoskeleton device: height between 60 and 76\", weight under 220 lbs.\n* Be able to tolerate upright standing for 30 minutes with assistance if needed.\n* Have normal joint range of motion for walking as determined by study staff.\n* Have sufficient strength to use the hemiwalker, bilateral canes or walker while wearing the RE.\n* Have stable blood pressure.\n* Be willing and able to give informed consent.\n* Be able and willing to comply with study procedures and follow directions and commands, verbal instructions, and follow-up requirements.\n\nExclusion Criteria:\n\n* Have a history of head injury, stroke, seizures, or any other significant neurological history other than MS.\n* Have a high degree of difficulty in thinking and problem solving that prevents me from participating in the study as determined by my performance on a special test taken during the screening visit.\n* Be currently taking steroids, benzodiazepines, antipsychotics, and\u002For neuroleptics as determined by study staff review of my medications.\n* Be pregnant.\n* Be completely reliant on a wheelchair.\n* Have joint contracture or spasticity of any limb that limits normal range of motion during walking with assistive devices as determined by study staff.\n* Have skin issues that would prevent wearing the RE.\n* Have pressure sore stage 2 or higher located in an area that would negatively affect weight bearing, harness fit, or therapist assistance.\n* Have orthopedic issues or history that will interfere with walking or limit the range of motion of the lower limbs (e.g., knee replacement, inflammation)\n* Have been hospitalized for heart attack, heart surgery or acute heart failure within 3 months of enrollment in study.\n* Have any other medical conditions that my doctor or physical therapist feels would affect my ability to use the robotic device.\n* Have a pacemaker or other implanted electrical device, brain stimulator, aneurysm clip (metal clips on the wall of a large artery), metallic prostheses (including metal pins and rods, heart valves, and internal hearing aids \\[cochlear implants\\]), permanent eyeliner, implanted delivery pumps, or shrapnel fragments.\n* Have dental implants- I should discuss any dental implants with the investigators.\n* Have been told by my doctor that it is unsafe for me to have a regular MRI as part of my medical care.","75 Years",{"count":54,"type":21},10,"INTERVENTIONAL",[57],"NA","The purpose of this research study is to evaluate the usefulness of a wearable robotic exoskeleton device (Ekso-GT), to improve learning and memory, and gait therapy in persons with walking disability due to Multiple Sclerosis. The study will evaluate the mobility, learning and memory, and walking abilities of individuals with multiple sclerosis who went through the traditional as compared to others who used the robotic exoskeleton as part of their therapy.",[60,61,29,62],"Multiple Sclerosis","Gait Disorders, Neurologic","Cognitive Impairment","2025-11-19",{"date":65,"type":37},"2025-11-24",{"date":67,"type":37},"2017-10-05",{"date":69,"type":21},"2027-12-30",{"name":71,"class":44},"Kessler Foundation"]